Insider Shareholders with Direct Ownership of Cti Biopharma Corp (CTIC)
This section provides a comprehensive overview of the insiders with direct ownership of Cti Biopharma Corp (CTIC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CTI BIOPHARMA CORP Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bruce J. Seeley
EVP, Chief Operating Officer |
11,405 | 0 | 43,905 $399,096 | 3 |
Dec 31, 2021
Added 6.87%
|
|
Bvf Partners L P
Director |
14,497,440 | 21,010,146 | 19,839 $180,336 | 6 |
Aug 09, 2022
Reduced 95.94%
|
|
Adam R Craig
President and CEO |
859,386 | 861,416 | 0 $0 | 33 |
Jun 26, 2023
Reduced 100.0%
|
|
Michael A Metzger
Director |
183,000 | 203,121 | 0 $0 | 5 |
Nov 08, 2022
Reduced 100.0%
|
|
David Kirske
EVP, Chief Financial Officer |
306,911 | 307,331 | 0 $0 | 25 |
Jun 26, 2023
Reduced 100.0%
|
|
Reed Vaughn Tuckson
Director |
0 | 48,639 | 0 $0 | 1 |
Jun 26, 2023
Reduced 100.0%
|
|
Matthew D Perry
Director |
0 | 43,139 | 0 $0 | 1 |
Jun 26, 2023
Reduced 100.0%
|
|
James K Fong
EVP & Chief Commercial Officer |
100,000 | 103,565 | 0 $0 | 3 |
Jun 26, 2023
Reduced 100.0%
|